The aforementioned results indicate that the function and fate of MDSC remain different in the tumor and peripheral lymphoid organs of pancreatic cancer, and IBC can orchestrate M2 macrophage, MDSC, and CD8+ T cells to serve as an antineoplastic agent. Here, CD8A is linked to pancreatic neoplasm.